CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities:
Net income	$ 68,825	$ 131,860
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	163,846	166,988
(Accretion) amortization of debt premium and discount, net	(144)	948
Deferred financing cost amortization	3,619	3,551
Accretion of above- and below-market leases, net	(8,224)	(9,646)
Tenant inducement amortization and other	1,789	1,814
Impairment of real estate assets	10,560	9,298
Gain on sale of real estate assets	(9,597)	(20,645)
Equity based compensation	4,607	5,611
Loss on extinguishment of debt, net	10,391	677
Changes in operating assets and liabilities:
Receivables, net	(42,672)	(7,628)
Deferred charges and prepaid expenses	(10,552)	(14,610)
Other assets	(201)	42
Accounts payable, accrued expenses and other liabilities	(12,683)	(17,253)
Net cash provided by operating activities	179,564	251,007
Investing activities:
Improvements to and investments in real estate assets	(158,120)	(169,529)
Acquisitions of real estate assets	(2,020)	(79,634)
Proceeds from sales of real estate assets	46,633	95,139
Purchase of marketable securities	(10,733)	(24,202)
Proceeds from sale of marketable securities	8,219	38,942
Net cash used in investing activities	(116,021)	(139,284)
Financing activities:
Repayment of secured debt obligations	(7,000)	0
Repayment of borrowings under unsecured revolving credit facility	(507,500)	(337,000)
Proceeds from borrowings under unsecured revolving credit facility	646,000	176,000
Proceeds from unsecured notes	498,880	399,216
Repayment of borrowings under unsecured term loans and notes	(182,479)	(200,000)
Deferred financing and debt extinguishment costs	(14,049)	(3,402)
Distributions to common stockholders	(170,397)	(167,772)
Repurchases of common shares	(25,007)	(14,563)
Repurchases of common shares in conjunction with equity award plans	(3,523)	(1,711)
Net cash provided by (used in) financing activities	234,925	(149,232)
Net change in cash, cash equivalents and restricted cash	298,468	(37,509)
Cash, cash equivalents and restricted cash at beginning of period	21,523	50,765
Cash, cash equivalents and restricted cash at end of period	319,991	13,256
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	318,540	10,809
Cash, cash equivalents and restricted cash at end of period	319,991	13,256
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amount capitalized of $2,177 and $1,404	94,593	87,170
Brixmor Operating Partnership LP
Operating activities:
Net income	68,825	131,860
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	163,846	166,988
(Accretion) amortization of debt premium and discount, net	(144)	948
Deferred financing cost amortization	3,619	3,551
Accretion of above- and below-market leases, net	(8,224)	(9,646)
Tenant inducement amortization and other	1,789	1,814
Impairment of real estate assets	10,560	9,298
Gain on sale of real estate assets	(9,597)	(20,645)
Equity based compensation	4,607	5,611
Loss on extinguishment of debt, net	10,391	677
Changes in operating assets and liabilities:
Receivables, net	(42,672)	(7,628)
Deferred charges and prepaid expenses	(10,552)	(14,610)
Other assets	(201)	42
Accounts payable, accrued expenses and other liabilities	(12,683)	(17,253)
Net cash provided by operating activities	179,564	251,007
Investing activities:
Improvements to and investments in real estate assets	(158,120)	(169,529)
Acquisitions of real estate assets	(2,020)	(79,634)
Proceeds from sales of real estate assets	46,633	95,139
Purchase of marketable securities	(10,733)	(24,200)
Proceeds from sale of marketable securities	8,219	38,942
Net cash used in investing activities	(116,021)	(139,282)
Financing activities:
Repayment of secured debt obligations	(7,000)	0
Repayment of borrowings under unsecured revolving credit facility	(507,500)	(337,000)
Proceeds from borrowings under unsecured revolving credit facility	646,000	176,000
Proceeds from unsecured notes	498,880	399,216
Repayment of borrowings under unsecured term loans and notes	(182,479)	(200,000)
Deferred financing and debt extinguishment costs	(14,049)	(3,402)
Partner distributions and repurchases of OP Units	(208,925)	(183,941)
Net cash provided by (used in) financing activities	224,927	(149,127)
Net change in cash, cash equivalents and restricted cash	288,470	(37,402)
Cash, cash equivalents and restricted cash at beginning of period	21,507	50,639
Cash, cash equivalents and restricted cash at end of period	309,977	13,237
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	308,526	10,790
Cash, cash equivalents and restricted cash at end of period	309,977	13,237
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amount capitalized of $2,177 and $1,404	$ 94,593	$ 87,170